haloperidol has been researched along with Adenoma, Basal Cell in 10 studies
Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Both normal pituitary fragments and pituitary adenomatous cells (from all types of adenomas studied) spontaneously released TRH in vitro." | 5.28 | Normal and adenomatous human pituitaries secrete thyrotropin-releasing hormone in vitro: modulation by dopamine, haloperidol, and somatostatin. ( Barret, A; Brandi, AM; Feinstein, MC; Le Dafniet, M; Lefebvre, P; Mechain, C; Peillon, F, 1990) |
| "To examine whether human atrial natriuretic peptide (hANP) has an agonistic effect on dopaminergic pathways, we studied the natriuretic action and the suppressive effect of hANP on aldosterone secretion before and during treatment with haloperidol or pergolide in nude mice harbouring heterotransplanted human CONN's adenoma tissue." | 3.67 | Human atrial natriuretic peptide (hANP) has no effect upon dopaminergic pathways: preliminary evidence in nude mice bearing heterotransplanted human CONN's adenoma tissue. ( Abdelhamid, S; Jungmann, E; Schöffling, K; Schumm-Draeger, PM; Timm, C, 1986) |
| "Both normal pituitary fragments and pituitary adenomatous cells (from all types of adenomas studied) spontaneously released TRH in vitro." | 1.28 | Normal and adenomatous human pituitaries secrete thyrotropin-releasing hormone in vitro: modulation by dopamine, haloperidol, and somatostatin. ( Barret, A; Brandi, AM; Feinstein, MC; Le Dafniet, M; Lefebvre, P; Mechain, C; Peillon, F, 1990) |
| "An ectopic ACTH secreting lung carcinoid was non-responsive to doses of bromocriptine up to 13 microM." | 1.26 | Bromocriptine suppresses ACTH secretion from human pituitary tumour cells in culture by a dopaminergic mechanism. ( Adams, EF; Ashby, MJ; Brown, SM; Mashiter, K; White, MC, 1981) |
| "Rats treated with haloperidol or bearing subcutaneous implants of prolactin-secreting tumors had elevated CSF prolactin levels compared to those observed in control rats." | 1.26 | Prolactin in human and rat serum and cerebrospinal fluid. ( Login, IS; MacLeod, RM, 1977) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (80.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Madhusoodanan, S | 1 |
| Steinberg, LR | 1 |
| Coleman, A | 1 |
| Bavli, S | 1 |
| Ishibashi, M | 2 |
| Yamaji, T | 2 |
| Adams, EF | 1 |
| Ashby, MJ | 1 |
| Brown, SM | 1 |
| White, MC | 1 |
| Mashiter, K | 1 |
| Gurkalo, VK | 1 |
| Zabezhinskiĭ, MA | 1 |
| Jungmann, E | 2 |
| Schwedes, U | 1 |
| Usadel, KH | 1 |
| Obert, I | 1 |
| Schöffling, K | 2 |
| Login, IS | 1 |
| MacLeod, RM | 1 |
| Le Dafniet, M | 1 |
| Lefebvre, P | 1 |
| Barret, A | 1 |
| Mechain, C | 1 |
| Feinstein, MC | 1 |
| Brandi, AM | 1 |
| Peillon, F | 1 |
| Teramoto, A | 1 |
| Fukushima, T | 1 |
| Schumm-Draeger, PM | 1 |
| Timm, C | 1 |
| Abdelhamid, S | 1 |
| Israel, JM | 1 |
| Jaquet, P | 1 |
| Vincent, JD | 1 |
1 review available for haloperidol and Adenoma, Basal Cell
| Article | Year |
|---|---|
Hyperprolactinemia Secondary to Pituitary Microadenoma Versus Haloperidol- A Diagnostic Enigma. A Case Report and Brief Review.
Topics: Adenoma; Antipsychotic Agents; Diagnosis, Differential; Haloperidol; Humans; Hyperprolactinemia; Mal | 2017 |
9 other studies available for haloperidol and Adenoma, Basal Cell
| Article | Year |
|---|---|
Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
Topics: Acromegaly; Adenoma; Adult; Bromocriptine; Cells, Cultured; Dopamine; Endorphins; Female; Growth Hor | 1984 |
Bromocriptine suppresses ACTH secretion from human pituitary tumour cells in culture by a dopaminergic mechanism.
Topics: Adenoma; Adrenocorticotropic Hormone; Adult; Bromocriptine; Carcinoid Tumor; Cells, Cultured; Dopami | 1981 |
[Effects of apomorphine and haloperidol on experimental hepatocarcinogenesis].
Topics: Adenoma; Adenoma, Bile Duct; Animals; Apomorphine; Cell Transformation, Neoplastic; Diethylnitrosami | 1983 |
Missing endogenous dopaminergic inhibition of aldosterone secretion in human CONN's adenoma tissue after heterotransplantation to thymusaplastic mice.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenocorticotropic Hormone; Aldosterone; Animals; Bromocriptine; | 1983 |
Prolactin in human and rat serum and cerebrospinal fluid.
Topics: Adenoma; Animals; Female; Haloperidol; Humans; Neoplasm Transplantation; Pituitary Neoplasms; Prolac | 1977 |
Normal and adenomatous human pituitaries secrete thyrotropin-releasing hormone in vitro: modulation by dopamine, haloperidol, and somatostatin.
Topics: Adenoma; Chromatography, High Pressure Liquid; Dopamine; Female; Haloperidol; Humans; In Vitro Techn | 1990 |
Prolactin secretion by mixed ACTH-prolactin pituitary adenoma cells in culture.
Topics: Adenoma; Adrenocorticotropic Hormone; Adult; Cells, Cultured; Corticotropin-Releasing Hormone; Cushi | 1985 |
Human atrial natriuretic peptide (hANP) has no effect upon dopaminergic pathways: preliminary evidence in nude mice bearing heterotransplanted human CONN's adenoma tissue.
Topics: Adenoma; Aldosterone; Animals; Atrial Natriuretic Factor; Haloperidol; Humans; Mice; Mice, Nude; Nat | 1986 |
The electrical properties of isolated human prolactin-secreting adenoma cells and their modification by dopamine.
Topics: Adenoma; Bromocriptine; Domperidone; Dopamine; Dose-Response Relationship, Drug; Electrophysiology; | 1985 |